<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2574</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2018.106111</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Molecular Docking, Quantum Chemical Analyses of Molecular Structure and Spectroscopic Investigations of N-[1-(1-Benzothien-2-yl)ethyl]-N-hydroxyurea: A Combined Experimental and Theoretical Studies&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Charanya</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sampathkrishnan</surname><given-names>S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bhaskaran</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Balamurugan</surname><given-names>N.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>14</day><month>11</month><year>2018</year></pub-date><volume>10</volume><issue>21</issue><fpage>106</fpage><lpage>111</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>The structure of N-[1-(1-benzothien-2-yl)ethyl]-N-hydroxyurea (C11H12N2O2S, Zileuton) was investigated on the basis of spectroscopic data and theoretical calculations. The optimized geometry, intensity and frequency of the vibrational bands of the compound was obtained by Density Functional Theory(DFT) using B3LYP/6-31+G(d,p) basis set. The FT-IR and FT-Raman spectra of the Zileuton were recorded in the range of 4000__ampersandsignndash;400 cm__ampersandsignminus;1 and 4000__ampersandsignndash;400 cm__ampersandsignminus;1, respectively. The harmonic vibrational frequencies were calculated and scaled values have been compared with experimental FT-IR and FT-Raman spectra. The observed and calculated frequencies are found to be in good agreement. A detailed interpretation of the FT-IR and FT-Raman spectra were also reported based on Potential Energy Distribution (PED). To confirm the potential of Zileuton molecule in the area of pharmaceutics, we have also calculated a series of drug likeness parameters. Possibly important biological activity of Zileuton molecule was also confirmed by molecular docking study.&#13;
</p></abstract><kwd-group><kwd>Zileuton</kwd><kwd> DFT</kwd><kwd> FT-IR</kwd><kwd> FT-Raman</kwd><kwd> Molecular docking</kwd></kwd-group></article-meta></front></article>
